GHUCCTS

News

Share This
  • May 01, 2020

NIH awards $24M to GHUCCTS to support clinical and translational research

WASHINGTON (May 1, 2020) - The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health.

The competitive renewal represents the third 5-year award for the center, which has secured $89.8 million in research funding over 15-years for its member institutions: Georgetown University, Howard University, MedStar Health Research Institute, the Washington DC Veterans Affairs Medical Center and Oak Ridge National Laboratory.

Led by principal investigators Joseph Verbalis, MD, from Georgetown University and Thomas Mellman, MD, from Howard University, the mission of GHUCCTS is to advance research and training with excellence, innovation, collaboration, and efficiency while realizing the potential of the unique capacities of its constituent institutions for developing new technologies, promoting ethical clinical and translational research, and engaging the diverse populations of our communities that have been historically underrepresented in clinical research, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.

“One of the major missions of GHUCCTS has been to stimulate and support the growth of team science,” says Verbalis, a professor of medicine at Georgetown. “Advances in solving the complex and challenging health problems we face today can be achieved more quickly and efficiently by collaborations among investigators from different scientific disciplines working together on common problems.”

“GHUCCTS was built on a unique model of co-leadership between Georgetown and Howard University, a Historically Black University,” says Mellman, a professor of psychiatry at Howard. “The partnership has influenced prioritizing health disparities and diversity in our training and research missions. Diversity of institutional cultures and of the disciplines represented in our programs has been a founding and enduring strength of GHUCCTS.” 

As one of 60 national CTSA programs, GHUCCTS has transformed research in the greater Washington DC region. Verbalis and Mellman along with faculty members from all of the GHUCCTS institutions and numerous collaborators across the region have achieved impressive goals over the last 10 years, including:

With this new award, GHUCCTS will continue to develop and promote innovative clinical and translational science research to improve the health of the greater Washington DC population.

Download PDF

Related News

TBS Grant Writing Workshop (GWW) Series registration is now open for the 2021-2022 cycle.

Sep 08, 2021

Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) Translational Biomedical Science (TBS) Program is offering a 6 month Grant Writing Workshop Series

GHUCCTS announces 2021 KL2 Scholars Dr. Maurice Fluitt & Dr. Roxanne Mirabal-Beltran

Aug 10, 2021

After our 11th highly competitive application cycle, unfortunately delayed due to COVID-related research closures, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Dr. Maurice Fluitt and Dr. Roxanne Mirabal-Beltran as a KL2 Scholar.

GHUCCTS featured in National Black Nurses Association for Howard University's Novavax COVID-19 Clinical Trial

May 28, 2021

GHUCCTS is featured in the Winter 2021 edition of the National Black Nurses Association (NBNA) Newsletter for our work helping with the planning, recruitment, and implementation efforts of the Novavax COVID-19 vaccine study at Howard University.

Close